Log in to save to my catalogue

Safety and Efficacy of a Typhoid Conjugate Vaccine in Malawian Children

Safety and Efficacy of a Typhoid Conjugate Vaccine in Malawian Children

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8202713

Safety and Efficacy of a Typhoid Conjugate Vaccine in Malawian Children

About this item

Publication information

Publisher

Boston: Massachusetts Medical Society

More information

Scope and Contents

Contents

The efficacy of a Vi polysaccharide typhoid conjugate vaccine (Vi-TCV) was assessed in 28,130 Malawian children who were 9 months to 12 years of age. The incidence of blood culture–confirmed typhoid fever was significantly lower among children who received Vi-TCV than among those who received a control vaccine.

Alternative Titles

Full title

Safety and Efficacy of a Typhoid Conjugate Vaccine in Malawian Children

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8202713

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8202713

Other Identifiers

ISSN

0028-4793

E-ISSN

1533-4406

DOI

10.1056/NEJMoa2035916

How to access this item